China Aims to Cement Its Place at Forefront of Biomedical Innovation with New 5-Year Plan

China aims to cement its place at forefront of biomedical innovation with new 5-year plan

China’s Next Industrial Leap Is Medicine

China wants first-in-class medicines developed at home to account for at least 25% of the global total by 2030. That would place Chinese laboratories at the origin of 1 in 4 drugs that attack disease through a new mechanism and can establish...

China Targets 3.5 Trillion Yuan Pharmaceutical Industry by 2030

China Targets 3.5 Trillion Yuan Pharmaceutical Industry by 2030 - Beijing’s five-year blueprint targets annual growth above 20% for innovative drugs and seeks global scale for domestic biotechs

Biomedicine powerhouse: China targets quarter of global first-in-class drugs

New five-year plan aims to turn the sector into a pillar industry by 2030, driven by breakthroughs in technologies across critical fields.

China aims for first-in-class drugs to exceed 25% of global total by 2030

China aims for its first-in-class new drugs to account for more than 25% of the global total during the 15th Five-Year Plan period (2026-2030).